Solasia Pharma K.K. (TYO:4597)

Solasia Pharma K.K. Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	8,885	7,563	7,846	7,579	8,230	14,285
Market Cap Growth	10.13%	-3.61%	3.52%	-7.91%	-42.38%	0.41%
Enterprise Value	7,593	5,835	6,839	7,128	6,469	13,176
Last Close Price	33.00	29.00	36.00	45.00	49.00	107.00
PS Ratio	20.71	17.63	24.83	12.28	7.54	25.56
PB Ratio	5.07	4.32	6.79	4.04	3.09	5.52
P/TBV Ratio	5.07	4.32	6.79	10.00	7.54	28.12
EV/Sales Ratio	17.70	13.60	21.64	11.55	5.92	23.57
Debt / Equity Ratio	0.05	0.05	0.02	0.03	0.01	0.03
Net Debt / Equity Ratio	-0.74	-0.74	-0.74	-0.36	-0.29	-0.24
Net Debt / EBITDA Ratio	1.57	1.57	0.49	1.05	0.40	0.33
Net Debt / FCF Ratio	1.53	1.53	0.83	1.86	0.37	0.26
Asset Turnover	0.25	0.25	0.18	0.23	0.35	0.13
Inventory Turnover	1.84	1.84	1.05	4.12	-	-
Quick Ratio	5.64	5.64	5.79	2.71	3.38	1.72
Current Ratio	6.06	6.06	6.56	3.33	3.53	1.83
Return on Equity (ROE)	-60.25%	-60.25%	-128.08%	-49.02%	-97.08%	-79.44%
Return on Assets (ROA)	-30.62%	-30.62%	-67.88%	-26.55%	-49.20%	-33.90%
Return on Capital Employed (ROCE)	-46.90%	-46.90%	-166.80%	-58.80%	-90.60%	-91.10%
Earnings Yield	-9.86%	-11.58%	-24.74%	-14.67%	-30.96%	-17.35%
FCF Yield	-	-11.20%	-13.18%	-4.74%	-25.20%	-17.33%
Buyback Yield / Dilution	-19.53%	-19.53%	-18.18%	-10.62%	-16.78%	-10.88%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.